These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8465795)

  • 41. Ibopamine does not affect insulin resistance in patients with type I diabetes.
    Benzi L; Sabino F; Ciccarone AM; Cecchetti P; Di Cianni G; Cicchetti V; Navalesi R
    Cardiology; 1990; 77 Suppl 5():63-6. PubMed ID: 2279254
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Ibopamine in the treatment of congestive heart failure. Multicenter follow-up study].
    Fonseca C; Gouveia R; Ceia F; Mota E; Coelho EM; Gil V; Riva E; Astorga MA; Gomes RS; Luís AS
    Rev Port Cardiol; 1992 Jun; 11(6):515-23. PubMed ID: 1503784
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The safety profile of ibopamine, an alternative substance for treatment of chronic heart failure.
    Holubarsch C; Just H
    Cardiology; 1990; 77 Suppl 5():1-8. PubMed ID: 2279251
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hemodynamic effects and pharmacokinetics of long-term therapy with ibopamine in patients with chronic heart failure.
    Itoh H; Taniguchi K; Tsujibayashi T; Koike A; Sato Y; Nakamura S
    Cardiology; 1992; 80(5-6):356-66. PubMed ID: 1451123
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Endothelium dependent relaxation in two different models of chronic heart failure and the effect of ibopamine.
    Buikema H; van Gilst WH; van Veldhuisen DJ; de Smet BJ; Scholtens E; Lie KI; Wesseling H
    Cardiovasc Res; 1993 Dec; 27(12):2118-24. PubMed ID: 8313417
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Early pharmacologic intervention may prevent the deterioration in endothelial function after experimental myocardial infarction in rats: effects of ibopamine and captopril.
    Buikema H; van Veldhuisen DJ; Hegeman H; van Gilst WH
    J Card Fail; 1997 Jun; 3(2):125-32. PubMed ID: 9220312
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ibopamine.
    Arzneimittelforschung; 1986 Feb; 36(2A):285-407. PubMed ID: 3707639
    [No Abstract]   [Full Text] [Related]  

  • 48. Multicenter study on the clinical efficacy of chronic ibopamine administration.
    Dei Cas L; Barilli AC; Metra M; Fracalossi C; Lomanto B; Santambrogio S; Pinca L; Longhini C; Cavicchi E; Maggi GC
    Arzneimittelforschung; 1986 Feb; 36(2A):383-5. PubMed ID: 3707655
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ibopamine in the treatment of mild chronic heart failure in elderly patients. A double-blind, placebo-controlled study.
    Azzolini A; Guffanti E; Ronzitti M; Tantalo L; Colantoni A; Pizzorni C
    Cardiology; 1990; 77 Suppl 5():89-95. PubMed ID: 2279258
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term therapy of chronic congestive heart failure with ibopamine: a multicenter trial.
    Rolandi E; Sabino F; Cantoni V; Ghirardi P; Marchetti GV; Cicchetti V
    J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S93-103. PubMed ID: 2483446
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Effects of ibopamine on the peripheral circulation of normal subjects after protracted administration].
    Musacci GF; Longhini C; Ansani L; Toselli T; Pinca L; Dell'Acqua G
    Cardiologia; 1982 Dec; 27(12):1171-5. PubMed ID: 6927475
    [No Abstract]   [Full Text] [Related]  

  • 52. Renal and neurohumoral effects of ibopamine and metoclopramide in normal man.
    Girbes AR; van Veldhuisen DJ; Smit AJ; Drent-Bremer A; Meijer S; Reitsma WD
    Br J Clin Pharmacol; 1991 Jun; 31(6):701-4. PubMed ID: 1678273
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Absence of proarrhythmic effects of ibopamine in patients with congestive heart failure.
    Caponnetto S; Terrachini V; Canale C; Bruzzone F; Licciardello L; Marchetti GV
    J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S104-10. PubMed ID: 2483435
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of the acute hemodynamic effects of ibopamine and dopamine in chronic congestive heart failure.
    Sannia L; Ibba GV; Castellaccio M; Dore L
    Arzneimittelforschung; 1986 Feb; 36(2A):355-9. PubMed ID: 3707649
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A survey of 311 patients receiving ibopamine mainly during hospital treatment for severe congestive heart failure.
    Ferrari V; Sher D; Marchetti G
    Arzneimittelforschung; 1986 Feb; 36(2A):398-405. PubMed ID: 3707657
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Strain gauge plethysmography in the evaluation of the effect of acute administration of ibopamine on the peripheral circulation of normal subjects].
    Longhini C; Ansani L; Musacci GF; Fratti D; Toselli T; Lupato L
    Cardiologia; 1982 Dec; 27(12):1189-95. PubMed ID: 6927477
    [No Abstract]   [Full Text] [Related]  

  • 57. Ibopamine and survival in severe congestive heart failure: PRIME II.
    Massel D
    Lancet; 1997 Jul; 350(9071):147. PubMed ID: 9228992
    [No Abstract]   [Full Text] [Related]  

  • 58. [Changes in the cardio-thoracic index during the treatment with ibopamine].
    Piccini L; Castelli N; Mannolini G; Giannazzo G; Bordoni G; Pala AM
    Clin Ter; 1991 Jul; 138(2):83-6. PubMed ID: 1834404
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Mechanism of action of ibopamine: pharmacological effects of epinine and other metabolites].
    Ferrini R; Merlo L; Miragoli G
    Cardiologia; 1988 Jan; 33(1):49-53. PubMed ID: 2835159
    [No Abstract]   [Full Text] [Related]  

  • 60. Ibopamine as a valuable adjunct and substitute for dopamine in bridging therapy before heart transplantation.
    Kleber FX; Sabin GV; Thyroff-Friesinger U; Cabell B; Glogar D
    Cardiology; 1992; 81(2-3):121-4. PubMed ID: 1286470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.